HSBA
1,179
-0.05%↓
LLOY
92.9
+0.74%↑
BARC
382.75
+0.41%↑
LSE
8,454
+0.64%↑
STAN
1,572
+0.77%↑
HSBA
1,179
-0.05%↓
LLOY
92.9
+0.74%↑
BARC
382.75
+0.41%↑
LSE
8,454
+0.64%↑
STAN
1,572
+0.77%↑
HSBA
1,179
-0.05%↓
LLOY
92.9
+0.74%↑
BARC
382.75
+0.41%↑
LSE
8,454
+0.64%↑
STAN
1,572
+0.77%↑
HSBA
1,179
-0.05%↓
LLOY
92.9
+0.74%↑
BARC
382.75
+0.41%↑
LSE
8,454
+0.64%↑
STAN
1,572
+0.77%↑
HSBA
1,179
-0.05%↓
LLOY
92.9
+0.74%↑
BARC
382.75
+0.41%↑
LSE
8,454
+0.64%↑
STAN
1,572
+0.77%↑
24h
Atual
Mín
2880
Máximo
2980
Rendimento | 222M |
|---|---|
Vendas | 52M |
P/E Médio do Setor | 8.417 54.048 |
EPS | 3.01 |
Margem de lucro | 427.263 |
EBITDA | 242M |
Próximos Ganhos | 28 de mai. de 2026 |
|---|
Capitalização de Mercado | 2.1B |
|---|---|
Abertura anterior | 2956.01 |
Fecho anterior | 2955 |
By Acuity
50%
50%
160 / 441 Ranking em Finance
O desempenho passado não é um indicador confiável de resultados futuros.
23 de mar. de 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Ler
23 de mar. de 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Ler
23 de mar. de 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Ler
23 de mar. de 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Ler
23 de mar. de 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Ler
23 de mar. de 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Ler
23 de mar. de 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Ler
23 de mar. de 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Ler
23 de mar. de 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Ler
23 de mar. de 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Ler
23 de mar. de 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Ler
23 de mar. de 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Ler
23 de mar. de 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Ler
23 de mar. de 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Ler
23 de mar. de 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Ler
23 de mar. de 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Ler
23 de mar. de 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Ler
23 de mar. de 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Ler
23 de mar. de 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Ler
23 de mar. de 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Ler
23 de mar. de 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Ler
23 de mar. de 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Ler
23 de mar. de 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Ler
23 de mar. de 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Ler
23 de mar. de 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Ler
23 de mar. de 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Ler
Variação de preço
By Acuity
Sentimento de Notícias
Neutral
Volatilidade
Abaixo da média
Volume de Notícias (RCV)
Abaixo da média
Custos administrativos e de venda
Custos Operacionais
Lucro antes de imposto
Vendas
Custo das vendas
Lucro bruto sobre vendas
Despesa com juros da dívida
EBITDA
Resultado Operacional
$